Skip to main content
. 2013 Jun 7;8(6):e66036. doi: 10.1371/journal.pone.0066036

Table 1. General characteristics of the study population.

(N = 111)
Male [n(%)] 67 (60%)
Age (years) 57±11.38
Black [n(%)] 21 (19%)
Follow up time (months) 21 (9–55)
Diabetes [n(%)] 27 (24%)
Tobacco use [n(%)] 57 (51%)
Body mass index (kg/m2) 26.8±5.26
Creatinine (mg/dL) 2.26±0.84
eGFR (ml/min/1,73 m2) 34.7±16.1
Proteinuria (g/24 h) 0.24 (0–0.79)
Hemoglobin (g/dL) 12.7±1.8
Potassium (mEq/L) 4.7 (4.3–5.1)
Magnesium (mEq/L) 1.9 (1.7–2.1)
Ionized calcium (mmol/L) 1.28±0.05
Phosphate (mg/dL) 3.78±0.72
Alkaline phosphatase (mg/dl) 81 (66–103)
PTH (pg/ml) 110 (63–193)
iFGF 23 (pg/ml) 47.3 (23.2–102.8)
CRP (mg/dl) 0.28 (0.12–0.77)
IL6 (pg/ml) 4.6 (2.7–8.4)
Total cholesterol (mg/dL) 184.2±37.7
LDL cholesterol (mg/dL) 101±28.2
HDL cholesterol (mg/dL) 51.5±14.3
Triglycerides (mg/dL) 125 (99–206)
Median systolic pressure (mmHg) 125 (116.7–137)
Mean diastolic pressure (mmHg) 78.6±10.9
Absence of systolic decency [n(%)] 32 (29%)
Non controlled hypertension [n(%)] 23 (21%)
Left ventricular mass index (g/m2) 102.3 (84.4–131.3)
Ejection fraction (%) 67 (62–70)
Calcium score (AU) 9 (0–334)

eGFR - estimated Glomerular Filtration Rate; iPTH - intact Parathyroid Hormone; FGF23 - Fibroblast Growth Factor 23; CRP - C-Reactive Protein; IL6 - Interleukin-6. Results in mean ± SD, median (interquartiles) or proportions.